Discover open access scientific publications

Search, annotate, share and cite publications

Publications by B. Sigal-Zafrani

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance Between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

PLoS ONE

Multidisciplinary

2016

English

Related publications

Estrogen Receptor, Progesterone Receptor, and HER2-neu Expression in First Primary Breast Cancers and Risk of Second Primary Contralateral Breast Cancer

Breast Cancer Research and Treatment

Cancer Research

Oncology

2012

English

Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index

Clinical Breast Cancer

Cancer Research

Oncology

2017

English

Expression of Estrogen and Progesterone Receptor Status in Breast Carcinoma Using Quick Score

Annals of Pathology and Laboratory Medicine

2018

English

Folate Intake and Risk of Breast Cancer by Estrogen and Progesterone Receptor Status in a Swedish Cohort

Cancer Epidemiology Biomarkers and Prevention

English

Effects of Leptin on Human Breast Cancer Cell Lines in Relationship to Estrogen Receptor and HER2 Status

International Journal of Oncology

Cancer Research

Oncology

2007

English

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

Journal of Clinical Oncology

English

Estrogen and Progesterone Receptor Status in Breast Cancer: A Cross-Sectional Study of 450 Women in Kerala, South India

World Journal of Surgical Oncology

Surgery

Oncology

2014

English

Macrodissection Prior to Closed System RT-qPCR Is Not Necessary for Estrogen Receptor and HER2 Concordance With IHC/FISH in Breast Cancer

Laboratory Investigation

English

Carotenoid Intakes and Risk of Breast Cancer Defined by Estrogen Receptor and Progesterone Receptor Status: A Pooled Analysis of 18 Prospective Cohort Studies

2012

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by B. Sigal-Zafrani

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance Between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

Related publications

Estrogen Receptor, Progesterone Receptor, and HER2-neu Expression in First Primary Breast Cancers and Risk of Second Primary Contralateral Breast Cancer

Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index

Expression of Estrogen and Progesterone Receptor Status in Breast Carcinoma Using Quick Score

Folate Intake and Risk of Breast Cancer by Estrogen and Progesterone Receptor Status in a Swedish Cohort

Effects of Leptin on Human Breast Cancer Cell Lines in Relationship to Estrogen Receptor and HER2 Status

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

Estrogen and Progesterone Receptor Status in Breast Cancer: A Cross-Sectional Study of 450 Women in Kerala, South India

Macrodissection Prior to Closed System RT-qPCR Is Not Necessary for Estrogen Receptor and HER2 Concordance With IHC/FISH in Breast Cancer

Carotenoid Intakes and Risk of Breast Cancer Defined by Estrogen Receptor and Progesterone Receptor Status: A Pooled Analysis of 18 Prospective Cohort Studies